Sanmartin Maria X, McKenna Ryan M, Ali Mir M, Krebs Jean D
Department of Health Professions, Hofstra University, 220 Hofstra University, Hempstead, NY 11549-2200, USA,
J Ment Health Policy Econ. 2020 Mar 1;23(1):19-25.
Research has documented a low rate of opioid use disorder (OUD) treatment utilization among individuals involved in the criminal justice system. However, racial disparities in sources of payment for OUD treatment have not been examined in the existing literature.
Although substance use disorder (SUD) treatment is relatively rare for all criminal justice system involved racial-groups, previous research has indicated that, among individuals with SUD, members of racial minority groups receive treatment at lower rates than their non-Hispanic White counterparts. Given the alarming rise of OUD in the US and the association between source of payment and utilization of health care services, this study seeks to quantify racial disparities in sources of payment for OUD treatment among individuals with criminal justice involvement.
Using data from the 2008-2016 National Survey of Drug Use and Health (NSDUH), this study analyzes data on non-incarcerated individuals with OUD who have had any criminal justice involvement in the previous 12 months. An extension of the Blinder-Oaxaca decomposition method for non-linear models is implemented to determine the extent that differences in OUD treatment utilization across non-Hispanic Blacks and non-Hispanic Whites are explained by observed and measurable characteristics and/or unobserved factors.
Results indicate that non-Hispanic Whites are more likely to have their OUD treatment paid by a court (10%) relative to non-Hispanic Blacks (4.0%). Black-White differences in measurable factors explain 87% of the disparity, while the rest is attributed to unobserved factors. Non-Hispanic Blacks are more likely to have their OUD treatment paid by public insurance (77% vs 36%) than non-Hispanic Whites and only 72% of this disparity can be explained by observed characteristics.
Our findings indicate racial disparities in sources of payment for OUD treatment among the criminal justice-involved population. Expansion of health insurance coverage and access to substance use disorder treatments would be beneficial for reducing health care disparities.
Equitable treatment options in the criminal justice system that incentivize OUD treatment availability may help address racial disparities in sources of payment among the criminal justice-involved population with OUD.
Future research should focus on understanding the main factors driving the court's treatment decisions among the criminal justice system involved individuals.
研究表明,刑事司法系统中的个体使用阿片类药物障碍(OUD)治疗的利用率较低。然而,现有文献尚未探讨OUD治疗支付来源方面的种族差异。
尽管对于所有涉及刑事司法系统的种族群体而言,物质使用障碍(SUD)治疗相对较少见,但先前的研究表明,在患有SUD的个体中,少数族裔群体成员接受治疗的比例低于非西班牙裔白人。鉴于美国OUD惊人的增长以及支付来源与医疗服务利用之间的关联,本研究旨在量化有刑事司法介入的个体在OUD治疗支付来源方面的种族差异。
本研究使用2008 - 2016年全国药物使用和健康调查(NSDUH)的数据,分析了在过去12个月中有任何刑事司法介入的患有OUD的非在押个体的数据。采用非线性模型的布林德 - 奥克亚分解方法的扩展来确定非西班牙裔黑人和非西班牙裔白人在OUD治疗利用方面的差异在多大程度上可由观察到的和可测量的特征及/或未观察到的因素来解释。
结果表明,相对于非西班牙裔黑人(4.0%),非西班牙裔白人更有可能由法院支付其OUD治疗费用(10%)。可测量因素中的黑白差异解释了87%的差距,其余归因于未观察到的因素。非西班牙裔黑人比非西班牙裔白人更有可能由公共保险支付其OUD治疗费用(77%对36%),并且这种差异中只有72%可由观察到的特征来解释。
我们的研究结果表明,在涉及刑事司法的人群中,OUD治疗支付来源存在种族差异。扩大医疗保险覆盖范围和增加获得物质使用障碍治疗的机会将有助于减少医疗保健差异。
刑事司法系统中鼓励提供OUD治疗的公平治疗选择可能有助于解决患有OUD的涉及刑事司法人群在支付来源方面的种族差异。
未来的研究应侧重于了解在涉及刑事司法系统的个体中驱动法院治疗决策的主要因素。